Projects per year
Fingerprint
Dive into the research topics where Aaron Mansfield is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy
Cunningham, B. B. T., Mansfield, A. & Wang, X. X.
8/1/23 → 7/31/24
Project: Research project
-
Degron Disruption in Small Cell Lung Cancer
Congressionally Directed Medical Research Programs
1/1/21 → …
Project: Research project
-
Blood-based biomarker of therapeutic efficacy for mesothelioma
7/10/20 → 6/30/22
Project: Research project
-
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma The ATOMIC-Meso Randomized Clinical Trial
the ATOMIC-Meso Study Group, 2024, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study
Subbiah, V., Hu, M. I., Mansfield, A. S., Taylor, M. H., Schuler, M., Zhu, V. W., Hadoux, J., Curigliano, G., Wirth, L., Gainor, J. F., Alonso, G., Adkins, D., Godbert, Y., Ahn, M. J., Cassier, P. A., Cho, B. C., Lin, C. C., Zalutskaya, A., Barata, T., Trask, P., & 4 others , Jan 1 2024, In: Thyroid. 34, 1, p. 26-40 15 p.Research output: Contribution to journal › Article › peer-review
-
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study
Griesinger, F., Curigliano, G., Subbiah, V., Baik, C. S., Tan, D. S., Lee, D. H., Misch, D., Garralda, E., Kim, D. W., van der Wekken, A. J., Gainor, J. F., Paz-Ares, L., Liu, S. V., Kalemkerian, G. P., Bowles, D. W., Mansfield, A. S., Lin, J. J., Smoljanovic, V., Rahman, A., Zalutskaya, A., & 3 others , Feb 1 2024, In: Future oncology (London, England). 20, 6, p. 297-306 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
for the PAPILLON Investigators, Nov 30 2023, In: New England Journal of Medicine. 389, 22, p. 2039-2051 13 p.Research output: Contribution to journal › Article › peer-review
-
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors
Barham, W., Hsu, M., Liu, X., Harrington, S. M., Hirdler, J. B., Gicobi, J. K., Zhu, X., Zeng, H., Pavelko, K. D., Yan, Y., Mansfield, A. S. & Dong, H., Jan 1 2023, In: ImmunoHorizons. 7, 1, p. 125-139 15 p.Research output: Contribution to journal › Article › peer-review
Open Access